Eurizon SLJ Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.83M Buy
35,435
+156
+0.4% +$43.2K 2.89% 12
2026
Q1
$10.5M Sell
35,279
-4,371
-11% -$1.3M 4.99% 4
2025
Q4
$10.8M Buy
+39,650
New +$10.8M 4.29% 7

Other funds holding CME

Eurizon SLJ Capital's CME Position: Q2 2026 in Review

Eurizon SLJ Capital increased its CME Group (CME) stake by 0.44% in Q2 2026, buying an estimated $43.2K and bringing the position to 35,435 shares worth $7.83M. The position accounts for 2.89% of the portfolio, ranked #12.

Eurizon SLJ Capital first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.8M in Q4 2025. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Eurizon SLJ Capital held 35,435 shares of CME Group worth $7.83M as of Q2 2026.
  • Eurizon SLJ Capital bought 156 CME Group shares in Q2 2026, an estimated $43.2K.
  • CME Group made up 2.89% of Eurizon SLJ Capital's portfolio in Q2 2026, its #12 holding.
  • Eurizon SLJ Capital first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Eurizon SLJ Capital's CME Group position peaked at $10.8M in Q4 2025.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Eurizon SLJ Capital's 13F filing for Q2 2026, filed 3 Aug 2026.